An Exploratory, Double-arm, 8-week Study to Explore the Feasibility and Acceptability of Abbreviated Treatment with CT-156 in People with Schizophrenia.

NCT06486948 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
58
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Click Therapeutics, Inc.

Collaborators